Discovery of diazepane amide DORAs and 2-SORAs enabled by exploration of isosteric quinazoline replacements
- 1 November 2015
- journal article
- Published by Elsevier in Bioorganic & Medicinal Chemistry Letters
- Vol. 25 (21) , 4992-4999
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- International Union of Basic and Clinical Pharmacology. LXXXVI. Orexin Receptor Function, Nomenclature and PharmacologyPharmacological Reviews, 2012
- Orexin Receptor Antagonism, a New Sleep-Enabling Paradigm: A Proof-of-Concept Clinical TrialClinical Pharmacology & Therapeutics, 2012
- Orexin receptors as therapeutic drug targets2012
- Connectomics of orexin-producing neurons: interface of systems of emotion, energy homeostasis and arousalTrends in Pharmacological Sciences, 2011
- Hypocretin Antagonists in Insomnia Treatment and BeyondCurrent Pharmaceutical Design, 2011
- Orexin Receptors: Pharmacology and Therapeutic OpportunitiesAnnual Review of Pharmacology and Toxicology, 2011
- The brain hypocretins and their receptors: mediators of allostatic arousalCurrent Opinion in Pharmacology, 2009
- Promotion of sleep by targeting the orexin system in rats, dogs and humansNature Medicine, 2007
- Orexins and Orexin Receptors: A Family of Hypothalamic Neuropeptides and G Protein-Coupled Receptors that Regulate Feeding BehaviorCell, 1998
- The hypocretins: Hypothalamus-specific peptides with neuroexcitatory activityProceedings of the National Academy of Sciences, 1998